Cargando…
Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer
BACKGROUND: Inflammatory breast cancer (IBC) is a highly angiogenic disease; thus, antiangiogenic therapy should result in a clinical response. However, clinical trials have demonstrated only modest responses, and the reasons for these outcomes remain unknown. Therefore, the purpose of this retrospe...
Autores principales: | Arias-Pulido, Hugo, Chaher, Nabila, Gong, Yun, Qualls, Clifford, Vargas, Jake, Royce, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474178/ https://www.ncbi.nlm.nih.gov/pubmed/22813402 http://dx.doi.org/10.1186/1471-2407-12-298 |
Ejemplares similares
-
EphA2, vascular endothelial growth factor, and vascular endothelial growth factor correlate with adverse outcomes and poor survival in patients with glioma
por: Shen, Likui, et al.
Publicado: (2021) -
Vascular Inflammatory Diseases and Endothelial Phenotypes
por: Immanuel, Jenita, et al.
Publicado: (2023) -
Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
por: Moon, Jeong Min, et al.
Publicado: (2018) -
Cyclooxygenase Isoenzyme-2 and Vascular Endothelial Growth Factor are Associated with Poor Prognosis in Esophageal Adenocarcinoma
por: Prins, M. J. D., et al.
Publicado: (2012) -
Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signalling
por: Weidenaar, A C, et al.
Publicado: (2011)